Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trialJ. Neurosurg. 2022 Apr 15;[EPub Ahead of Print], SR Dashti, RJ Kadner, BS Folley, JP Sheehan, DY Han, RJ Kryscio, MB Carter, LBE Shields, BM Plato, RV La Rocca, AC Spalding, TL Yao, JF Fraser
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.